Skip to main content
SpringerLink
Log in

Biochemical Markers of Bone Turnover

  • Chapter
Clinical Trials in Osteoporosis

Part of the book series: Clinical Trials ((CLINICAL))

Abstract

The routine clinical assessment of bone mineral density (BMD) is best undertaken by the use of dual-energy X-ray absorptiometry (DXA) and ultrasound scans. These techniques will establish BMD at a particular time. Using serial DXA measurements it is possible to measure a change in BMD over a set period of time. It is presumed that these measured changes in BMD are caused by alterations in bone turnover, but they are not direct measurements of bone turnover. Furthermore, DXA scans and ultrasound can only indicate that loss of BMD has occurred, a single measurement cannot indicate that bone loss is occurring, and might lead to a lowered BMD in the future. These radiological and ultrasound techniques have other limitations, not least inherent imprecision of the methods, which means that there have to be considerable changes in bone turnover before changes in BMD can be noticed. For example, the 1–2% imprecision of DXA measurement limits scanning to 6-monthly intervals, so that observed changes are certain to be owing to bone loss and not imprecision. The skilled nature of these techniques combined with the need for special equipment, and in the case of DXA exposure to ionizing radiation, has fueled the search for useful and reliable markers of bone turnover.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Calvo, M.S., Eyre, D.R. and Gundberg, C.M. (1996). Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 17:333–68.

    Article  PubMed  CAS  Google Scholar 

  2. Reid, K.B.M. (1974). A collagen-like amino acid sequence in a polypeptide chain of human C1q (a subcomponent of the first component of complement). Biochem J 141:189–203.

    PubMed  CAS  Google Scholar 

  3. Deacon, A.C., Hulme, P., Hesp, R. et al. (1987). Estimation of whole body bone resorption rate: a comparison of urinary total hydroxyproline excretion with two radioisotopic tracer methods in osteoporosis. Clin Chim Acta 166:297–306.

    Article  PubMed  CAS  Google Scholar 

  4. Reed, P., Holbrook, I.B., Gardener, M.L.G. et al. (1991). Simple, optimized liquid-chromatographic method for measuring total hydroxyproline in urine evaluated. Clin Chem 37:285–90.

    PubMed  CAS  Google Scholar 

  5. Bettica, P., Moro, L., Robins, S.P. et al. (1992). Bone resorption markers galactosyl hydroxylysine, pyridinium crosslinks and hydroxyproline compared. Clin Chem 38:2313–18.

    PubMed  CAS  Google Scholar 

  6. Moro, L., Gazzarrini, C., Crivellari, D. et al. (1993). Biochemical markers for detecting bone metastases in patients with breast cancer. Clin Chem 39:131–4.

    PubMed  CAS  Google Scholar 

  7. Seibel, M.J., Robins, S.P. and Bilezikian, J.P. (1992). Urinary pyridinium crosslinks of collagen-specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 3:263–70.

    Article  CAS  PubMed  Google Scholar 

  8. James, I. and Crowley, C. (1993). Assay of pyridinium crosslinks in serum using narrow bore ion paired reversed phase high performance liquid chromatography. J Chromatogr 612:41–8.

    Article  PubMed  CAS  Google Scholar 

  9. Ogawa, T., Ono, T., Tsuda, M. et al. (1982). A novel fluor in insoluble collagen: a crosslinking moiety in collagen molecule. Biochem Biophys Res Commun 107:1252–7.

    Article  PubMed  CAS  Google Scholar 

  10. Uebelhart, D., Gineyts, E., Chapuy, M.-C. et al. (1990). Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 8:87–96.

    Article  PubMed  CAS  Google Scholar 

  11. Robins, S.P. (1995). Collagen crosslinks in metabolic bone disease. Acta Orthop Scand 66(Suppl 266):171–5.

    Google Scholar 

  12. Eyre, D.R., Koob, T.J. and Van Ness, K.P. (1984). Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography. Anal Biochem 137:380–8.

    Article  PubMed  CAS  Google Scholar 

  13. Kollerup, G., Thamsborg, G., Bathia, H. et al. (1992). Quantitation of urinary hydroxypyridinium cross-links from collagen by high performance liquid chromatography. Scand J Clin Lab Invest 52:657–62.

    PubMed  CAS  Google Scholar 

  14. Robins, S.P., Woitge, H.W., Hesley, R.P. et al. (1994). Direct, enzyme linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 9:1643–9.

    PubMed  CAS  Google Scholar 

  15. Abbiati, G., Rigoldi, M., Frignani, S. et al. (1994). Determination of pyridinium crosslinks in plasma and serum by high performance liquid chromatography. J Chromatogr 656:303–10.

    Article  CAS  Google Scholar 

  16. Robins, S.P., Duncan, A., Wilson, N. et al. (1996). Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation. Clin Chem 42:1621–6.

    PubMed  CAS  Google Scholar 

  17. Beardsworth, L.J., Eyre, D.R. and Dickson, I.R. (1990). Changes with age in the urinary excretion of lysyl and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Miner Res 5:671–6.

    PubMed  CAS  Google Scholar 

  18. Gerrits, M.I., Thijssen, J.H.H. and van Rijn, H.J.M. (1995). Determination of pyridinoline and deoxypyridinoline in urine, with special attention to retaining their stability. Clin Chem 41:571–4.

    PubMed  CAS  Google Scholar 

  19. McLaren, A.M., Isdale, A.H., Whiting, P.H. et al. (1993). Physiological variations in the urinary excretion of pyridinium crosslinks of collagen. Br J Rheum 32:307–12.

    Article  CAS  Google Scholar 

  20. Bjorgaas, M., Haug, E. and Johnsen, H.J. (1999). The urinary excretion of deoxypyridinium cross-links is higher in diabetic than nondiabetic adolescents. Calcif Tissue Int 65:121–4.

    Article  PubMed  CAS  Google Scholar 

  21. Garnero, P., Gineyts, E., Arbault, P. et al. (1995). Different effects of bisphosphonate and oestrogen therapy on free and peptide bound bone crosslinks excretion. J Bone Miner Res 10:641–9.

    PubMed  CAS  Google Scholar 

  22. Kamel, S., Brazier, M., Rogez, J.C. et al. (1996). Different responses of free and peptide bound crosslinks to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency. J Clin Endocrinol Metab 81:3717–21.

    Article  PubMed  CAS  Google Scholar 

  23. Hanson, D.A., Weis, M.E., Bollen, A. et al. (1992). A specific immunoassay for monitoring human bone resorption: quantitation of type 1 collagen crosslinked N-telopeptides in urine. J Bone Miner Res 7:1251–8.

    PubMed  CAS  Google Scholar 

  24. Melkko, J., Niemi, S., Risteli, J. et al. (1990). Radioimmunoassay of the carboxyterminal propeptide of human type 1 procollagen. Clin Chem 36:1328–32.

    PubMed  CAS  Google Scholar 

  25. Bonde, M., Qvist, P., Fledelius, C. et al. (1994). Immunoassay for quantifying type 1 collagen degradation products in urine evaluated. Clin Chem 40:2022–5.

    PubMed  CAS  Google Scholar 

  26. Rosen, H.N., Moses, A.C., Garber, J. et al. (2000). Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 66:100–3.

    Article  PubMed  CAS  Google Scholar 

  27. Eriksen, E.F., Charles, P., Melsen, F. et al. (1993). Serum markers of type 1 collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res 8:127–32.

    PubMed  CAS  Google Scholar 

  28. Calvo, M.S., Eyre, D.R. and Gundberg, C.M. (1996). Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 17:333–68.

    Article  PubMed  CAS  Google Scholar 

  29. Ebeling, P.R., Atley, L.M., Guthrie, J.R. et al. (1996). Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 81:3366–71.

    Article  PubMed  CAS  Google Scholar 

  30. Kamel, S., Brazier, M., Rogez, J.C. et al. (1996). Different responses of free and peptide bound crosslinks to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency. J Clin Endocrinol Metab 81:3717–21.

    Article  PubMed  CAS  Google Scholar 

  31. Bonde, M., Fledelius, C., Qvist, P. et al. (1996). Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption. Clin Chem 42:1639–44.

    PubMed  CAS  Google Scholar 

  32. Zanze, M., Souberbielle, J.C., Kindermans, C. et al. (1997). Procollagen propeptide and pyridinium cross-links as markers of type I collagen turnover: sex-and age-related changes in healthy children. J Clin Endocrinol Metab 82:2971–9.

    Article  PubMed  CAS  Google Scholar 

  33. Price, C.P., Kirwan, A. and Vader, C. (1995). Tartrate resistant acid phosphatase as a marker of bone resorption. Clin Chem 41:641–3.

    PubMed  CAS  Google Scholar 

  34. Cheung, C.K., Panesar, N.S., Haines, C. et al. (1995). Immunoassay of a tartrate resistant acid phosphatase in serum. Clin Chem 41:679–86.

    PubMed  CAS  Google Scholar 

  35. Halleen, J.M., Hentunen, T.A., Karp, M. et al. (1998). Characterization of serum tartrate resistant acid phosphatase and development of a direct two site immunoassay. J Bone Miner Res 13:683–7.

    Article  PubMed  CAS  Google Scholar 

  36. Weiss, M.J., Henthorn, P.S., Lafferty, M.A. et al. (1986). Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. Proc Natl Acad Sci USA 83:7182–6.

    Article  PubMed  CAS  Google Scholar 

  37. Weiss, M.J., Ray, K., Henthorn, P.S. et al. (1988). Structure of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem 263:12002–10.

    PubMed  CAS  Google Scholar 

  38. Whyte, M.P. (1994). Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15:439–61.

    Article  PubMed  CAS  Google Scholar 

  39. Farley, J.R., Hall, S.L., Ilacas, D. et al. (1994). Quantification of skeletal alkaline phosphatase in osteoporotic serum by wheat germ agglutinin precipitation, heat inactivation, and a two-site immunoradiometric assay. Clin Chem 40:1749–56.

    PubMed  CAS  Google Scholar 

  40. van Hoof, V. and De Broe, M.E. (1994). Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns. Crit Rev Clin Lab Sci 31:197–293.

    PubMed  Google Scholar 

  41. Moss, D.W. (1982). Alkaline phosphatase isoenzymes. Clin Chem 28:2007–16.

    PubMed  CAS  Google Scholar 

  42. Price, C.P. (1993). Multiple forms of human serum alkaline phosphatase: detection and quantitation. Ann Clin Biochem 30:355–72.

    PubMed  Google Scholar 

  43. Rosalki, S.B. and Ying Foo, A. (1984). Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem 30:1182–6.

    PubMed  CAS  Google Scholar 

  44. Moss, D.W. and Edwards, R.K. (1984). Improved electrophoretic resolution of bone and liver alkaline phosphatases resulting from partial digestion with neuraminidase. Clin Chim Acta 143:177–82.

    Article  PubMed  CAS  Google Scholar 

  45. Mattiazzo, M. and Ramasamy, I. (1993). Wheat germ lectin affinity electrophoresis of serum alkaline phosphatase with commercially available agarose gels. Clin Chem 39:1404–7.

    PubMed  CAS  Google Scholar 

  46. Kuwana, T., Sugita, O. and Yakata, M. (1988). Reference limits of bone and liver alkaline phosphatase isoenzymes in the serum of healthy subjects according to age and sex as determined by wheat germ lectin affinity electrophoresis. Clin Chim Acta 173:273–80.

    Article  PubMed  CAS  Google Scholar 

  47. Sorensen, S. (1988). Wheat germ agglutinin method for measuring bone and liver isoenzymes of alkaline phosphatase assessed in postmenopausal osteoporosis. Clin Chem 34:1636–40.

    PubMed  CAS  Google Scholar 

  48. Behr, W. and Barnert, J. (1986). Quantification of bone alkaline phosphatase in serum by precipitation with wheat germ lectin: A simplified method and its clinical plausibility. Clin Chem 32:1960–6.

    PubMed  CAS  Google Scholar 

  49. Farley, J.R., Hall, S.L., Ilacas, D. et al. (1994). Quantification of skeletal alkaline phosphatase in osteoporotic serum by wheat germ agglutinin precipitation, heat inactivation, and a two-site immunoradiometric assay. Clin Chem 40:1749–56.

    PubMed  CAS  Google Scholar 

  50. Burlina, A., Plebani, M., Secchiero, S. et al. (1991). Precipitation method for separating and quantifying bone and liver alkaline phosphatase isoenzymes. Clin Biochem 24:417–23.

    Article  PubMed  CAS  Google Scholar 

  51. Rosalki, S.B., Ying Foo, A., Burlina, A. et al. (1993). Multicentre evaluation of Iso—ALP test kit for measurement of bone alkaline phosphatase activity in serum and plasma. Clin Chem 39:648–52.

    PubMed  CAS  Google Scholar 

  52. Lawson, G.M., Katzmann, J.A., Kimlinger, T.K. et al. (1985). Isolation and preliminary characterization of a monoclonal antibody that interacts preferentially with the liver isoenzyme of human alkaline phosphatase. Clin Chem 31:381–5.

    PubMed  CAS  Google Scholar 

  53. Hill, C.S. and Wolfert, R.L. (1989). The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase. Clin Chim Acta 186:315–20.

    Article  Google Scholar 

  54. Garnero, P. and Delmas, P.D. (1993). Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77:1046–53.

    Article  PubMed  CAS  Google Scholar 

  55. Panigrahi, K., Delmas, P.D., Singer, F.R. et al. (1994). Characteristics of a two Site immunoradiometric assay for human skeletal alkaline phosphatase serum. Clin Chem 40:822–8.

    PubMed  CAS  Google Scholar 

  56. England, T.E., Samsoondar, J. and Maw, G. (1994). Evaluation of the Hybritech Tandem-R Ostase immunoradiometric assay for skeletal alkaline phosphatase. Clin Biochem 27:187–9.

    Article  PubMed  CAS  Google Scholar 

  57. Van Hoof, V.O., Martin, M., Blockx, P. et al. (1995). Immunoradiometric method and electrophoretic system compared for quantifying bone alkaline phosphatase in serum. Clin Chem 41:853–7.

    PubMed  Google Scholar 

  58. Crofton, P.M. (1992). Wheat germ lectin affinity electrophoresis for alkaline phosphatase isoforms in children: age dependent reference ranges in liver and bone disease. Clin Chem 38:663–70.

    PubMed  CAS  Google Scholar 

  59. Okesina, A.B., Donaldson, D., Lascelles, P.T. et al. (1995). Effect of gestational age on levels of serum alkaline phosphatase isoenzymes in healthy pregnant women. Int J Gynaecol Obstet 48:25–9.

    Article  PubMed  CAS  Google Scholar 

  60. Melton, L.J., Khosla, S., Atkinson, E.J. et al. (1997). Relationship of bone turnover to bone density and fractures. J Bone Miner Res 12:1083–91.

    Article  PubMed  Google Scholar 

  61. Bouman, A.A., Scheffer, P.G., Ooms, M.E. et al. (1995). Two bone alkaline phosphatase assays compared with osteocalcin as a marker of bone formation in healthy elderly women. Clin Chem 41:196–9.

    PubMed  CAS  Google Scholar 

  62. Hauschka, P.V. and Carr, S.A. (1982). Calcium-dependent alpha helical structure in osteocalcin. Biochemistry 21:2538–47.

    Article  PubMed  CAS  Google Scholar 

  63. Koshihara, Y. and Hoshi, K. (1997). Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 12:431–8.

    Article  PubMed  CAS  Google Scholar 

  64. Liu, G. and Peacock, M. (1998). Age-related changes in serum uncarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 62:286–9.

    Article  PubMed  CAS  Google Scholar 

  65. Hart, J.P., Shearer, M.J., Klenerman, L. et al. (1985). Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J Clin Endocrinol Metab 60:1268–9.

    Article  PubMed  CAS  Google Scholar 

  66. Puchacz, E., Lian, J.B., Stein, G.S. et al. (1989). Chromosomal localization of the human osteocalcin gene. Endocrinology 124:2648–50.

    PubMed  CAS  Google Scholar 

  67. Price, P.A., Williamson, M.K. and Lothringer, J.W. (1981). Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 256:12760–6.

    PubMed  CAS  Google Scholar 

  68. Farrugia, W. and Melick, R.A. (1986). Metabolism of osteocalcin. Calcif Tissue Int 39:234–8.

    Article  PubMed  CAS  Google Scholar 

  69. Garnero, P., Grimaux, M., Seguin, P. et al. (1994). Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 9:255–64.

    PubMed  CAS  Google Scholar 

  70. Van Der Eems, K.L., Brown, R.D. and Gundberg, C.M. (1985). Circulating levels of 1, 25 dihydroxyvitamin D, alkaline phosphatase, hydroxyproline and osteocalcin associated with antler growth in white-tailed deer. Acta Endocrinol 118:407–14.

    Google Scholar 

  71. Demiaux, B., Arlot, M.E., Chapuy, M.C. et al. (1992). Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. J Clin Endocrinol Metab 74:1146–51.

    Article  PubMed  CAS  Google Scholar 

  72. Ducy, P., Desbois, C., Boyce, B.F. et al. (1996). Increased bone formation in osteocalcin deficient mice. Nature 382:448–52.

    Article  PubMed  CAS  Google Scholar 

  73. Masters, P.W., Jones, R.G., Purves, D.A. et al. (1994). Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 40:358–63.

    PubMed  CAS  Google Scholar 

  74. Lee, A.J., Hodges, S. and Eastell, R. (2000). Measurement of osteocalcin. Ann Clin Biochem 37:432–46.

    Article  PubMed  Google Scholar 

  75. Gundberg, C.M. and Weinstein, R.S. (1986). Multiple immunoreactive forms of osteocalcin in uraemic serum. J Clin Invest 77:1762–7.

    Article  PubMed  CAS  Google Scholar 

  76. Klein, G., Wadlington, E.L., Collins, E.D. et al. (1984). Calcitonin levels in sera of infants and children: relations to age and periods of bone growth. Calcif Tissue Int 36:635–8.

    Article  PubMed  CAS  Google Scholar 

  77. Tarallo, P., Henny, J., Fournier, B. et al. (1990). Plasma osteocalcin: biological variations and reference limits. Scand J Clin Lab Invest 50:649–55.

    PubMed  CAS  Google Scholar 

  78. Nielsen, H.K., Brixen, K., Kassem, M. et al. (1992). Inhibition of the morning cortisol peak abolishes the expected morning decrease in serum osteocalcin in normal males: evidence of a controlling effect of serum cortisol on the circadian rhythm in serum osteocalcin. J Clin Endocrinol Metab 74:1410–14.

    Article  PubMed  CAS  Google Scholar 

  79. Nielsen, H.K., Laurberg, P., Brixen, K. et al. (1991). Relations between diurnal variations in serum osteocalcin, cortisol, parathyroid hormone and ionized calcium in normal individuals. Acta Endocrinol 124:391–8.

    PubMed  CAS  Google Scholar 

  80. Morrison, N.A., Shine, J., Fragonas, J.-C. et al. (1989). 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246:1158–61.

    Article  PubMed  CAS  Google Scholar 

  81. Wenz, I., Reissmann, R. and Bornig, H. (1991). Determination of osteocalcin in serum by an ultramicro-ELISA with alkaline phosphatase as marker enzyme. Biomed Biochem Acta 50:145–9.

    CAS  Google Scholar 

  82. Kuronen, I., Kokko, H. and Parivianen, M. (1993). Production of monoclonal and polyclonal antibodies against human osteocalcin sequences and development of a two site ELISA for intact human osteocalcin. J Immunol Methods 163:233–40.

    Article  PubMed  CAS  Google Scholar 

  83. Monaghan, D.A., Power, M.J. and Fottrell, P.F. (1993). Sandwich enzyme immunoassay of osteocalcin in serum with use of an antibody against human osteocalcin. Clin Chem 39:942–7.

    PubMed  CAS  Google Scholar 

  84. Parivianen, M., Kuronen, I., Kokko, H. et al. (1994). Two-site enzyme immunoassay for measuring intact human osteocalcin in serum. J Bone Miner Res 9:347–54.

    Article  Google Scholar 

  85. Rosenquist, C., Bonde, M., Fledelius, C. et al. (1994). A simple enzyme-linked immunosorbent assay of human osteocalcin. Clin Chem 40:1258–64.

    PubMed  CAS  Google Scholar 

  86. Kao, P.C., Riggs, B.L. and Schryver, P.G. (1993). Development of an osteocalcin chemiluminoimmunoassay. Clin Chem 39:1369–74.

    PubMed  CAS  Google Scholar 

  87. Power, M.J., Gosling, J.P. and Fottrell, P.F. (1989). Radioimmunoassay of osteocalcin with polyclonal and monoclonal antibodies. Clin Chem 35:1408–15.

    PubMed  CAS  Google Scholar 

  88. Delmas, P.D., Christiansen, C., Mann, K.G. et al. (1990). Bone gla protein (osteocalcin) assay standardization report. J Bone Miner Res 5:5–11.

    PubMed  CAS  Google Scholar 

  89. Diego, E.M.D., Guerrero, R. and de la Piedra, C. (1994). Six osteocalcin assays compared. Clin Chem 40:2071–7.

    CAS  Google Scholar 

  90. Colford, J., Sailer, D. and Longman, C. (1997). Five osteocalcin assays compared: tracer specificity, fragment interference, and calibration. Clin Chem 43:1240–1.

    PubMed  CAS  Google Scholar 

  91. Power, M.J., O’Dwyer, B., Breen, E. et al. (1991). Osteocalcin concentrations in plasma prepared with different anticoagulants. Clin Chem 37:281–4.

    PubMed  CAS  Google Scholar 

  92. Melkko, J., Kauppila, S., Niemi, S. et al. (1996). Immunoassay for intact amino terminal propeptide of human type 1 procollagen. Clin Chem 42:947–54.

    PubMed  CAS  Google Scholar 

  93. Olsen, B.R., Guzman, N.A., Engel, J. et al. (1977). Purification and characterization of a peptide from the carboxy-terminal region of chick tendon procollagen type I. Biochemistry 16:3030–6.

    Article  PubMed  CAS  Google Scholar 

  94. Smedsrod, B., Melkko, J., Risteli, L. et al. (1990). Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. Biochem J 271:345–50.

    PubMed  CAS  Google Scholar 

  95. Sorva, A., Taähtelaä, R., Risteli, J. et al. (1994). Familial high serum concentrations of the carboxy-terminal propeptide of type 1 procollagen (P1CP). Clin Chem 40:1591–3.

    PubMed  CAS  Google Scholar 

  96. Melkko, J., Hellevik, T., Risteli, L. et al. (1994). Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 179:405–12.

    Article  PubMed  CAS  Google Scholar 

  97. Savolainen, E.R., Goldberg, B., Leo, M.A. et al. (1984). Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease. Alcohol Clin Exp Res 8:384–9.

    PubMed  CAS  Google Scholar 

  98. Pedersen, B.J. and Bonde, M. (1994). Purification of human procollagen type 1 carboxyl terminal propeptide cleaved as in vivo from procollagen and used to calibrate a radioimmunoassay of the propeptide. Clin Chem 40:811–16.

    PubMed  CAS  Google Scholar 

  99. Linkhart, S.G., Linkhart, T.A., Taylor, A.K. et al. (1993). Synthetic peptide based immunoassay for amino terminal propeptide of type 1 procollagen: application for evaluation of bone formation. Clin Chem 39:2254–8.

    PubMed  CAS  Google Scholar 

  100. Risteli, J., Niemi, S., Trivedi, P. et al. (1988). Rapid equilibrium radioimmunoassay for the amino terminal propeptide of human type III procollagen. Clin Chem 34:715–18.

    PubMed  CAS  Google Scholar 

  101. Simon, L.S., Krane, S.M., Wortman, P.D. et al. (1984). Serum levels of type I and III procollagen fragments in Paget’s disease of bone. J Clin Endocrinol Metab 58:110–20.

    Article  PubMed  CAS  Google Scholar 

  102. Taubman, M.B., Goldberg, B. and Sherr, C.J. (1974). Radioimmunoassay for human procollagen. Science 186:1115–17.

    Article  PubMed  CAS  Google Scholar 

  103. Melkko, J., Niemi, S., Risteli, L. et al. (1990). Radioimmunoassay for the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328–32.

    PubMed  CAS  Google Scholar 

  104. Davis, B.H. and Madri, J.A. (1987). An immunohistochemical and serum ELISA study of type I and type III procollagen aminopropeptides in primary biliary cirrhosis. Am J Pathol 128:265–75.

    PubMed  CAS  Google Scholar 

  105. Rasmusson, H.B., Teisner, B., Bangsgaard-Petersen, F. et al. (1992). Quantification of fetal antigen 2 (FA2) in supernatants of cultured osteoblasts, normal human serum, and serum from patients with chronic renal failure. Nephrol Dial Transplant 7:902–7.

    Google Scholar 

  106. Ebeling, P.R., Peterson, J.M. and Riggs, B.L. (1992). Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases. J Bone Miner Res 7:1243–50.

    PubMed  CAS  Google Scholar 

  107. Tahtela, R., Turpeinen, M., Sorva, R. et al. (1997). The aminoterminal propeptide of type I procollagen: evaluation of a commercial radioimmunoassay kit and values in healthy subjects. Clin Biochem 30:35–40.

    Article  PubMed  CAS  Google Scholar 

  108. Orum, O., Hansen, M., Jensen, C.H. et al. (1996). Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism. Bone 2:157–63.

    Article  Google Scholar 

  109. Linkhart, S.G., Linkhart, T.A., Taylor, A.K. et al. (1993). Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formation. Clin Chem 39:2254–8.

    PubMed  CAS  Google Scholar 

  110. Crofton, P.M., Wade, J.C., Taylor, M.R. et al. (1997). Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren. Clin Chem 43:1577–81.

    PubMed  CAS  Google Scholar 

  111. Trivedi, P., Risteli, J., Risteli, J. et al. (1991). Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res 30:276–80.

    Article  PubMed  CAS  Google Scholar 

  112. Lieuw-A-Fa, M., Sierra, R.I. and Specker, B.L. (1995). Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age. J Bone Miner Res 10:849–53.

    PubMed  CAS  Google Scholar 

  113. Christenson, R.H. (1997). Biochemical markers of bone metabolism: an overview. Clin Biochem 30:573–93.

    Article  PubMed  CAS  Google Scholar 

  114. Blumsohn, A. and Eastell, R. (1997). The performance and utility of biochemical markers of bone turnover: do we know enough to use them in clinical practice? Ann Clin Biochem 34:449–59.

    PubMed  Google Scholar 

  115. Taylor, A.K., Lueken, S.A., Libanati, C. et al. (1994). Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am 20:589–607.

    PubMed  CAS  Google Scholar 

  116. Blumsohn, A., Hannon, R.A. and Eastell, R. (1995). Biochemical assessment of skeletal activity. Physical Med Rehab Clin North Am 6:483–505.

    Google Scholar 

  117. Eastell, R., Robins, S.P., Colwell, T. et al. (1993). Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporos Int 3:255–60.

    Article  PubMed  CAS  Google Scholar 

  118. Rosalki, S.B. (1998). Biochemical markers of bone turnover. Int J Clin Practice 52:255–6.

    CAS  Google Scholar 

  119. Demers, L.M. (1997). Clinical usefulness of markers of bone degradation and formation. Scand J Clin Lab Invest 227 (Suppl.):12–20.

    Article  CAS  Google Scholar 

  120. Garnero, P., Hausherr, E., Chapuy, M.C. et al. (1996). Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 11:1531–8.

    PubMed  CAS  Google Scholar 

  121. Seibel, M.J., Cosman, F., Shen, V. et al. (1993). Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and oestrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 8:881–9.

    PubMed  CAS  Google Scholar 

  122. Garnero, P., Shih, W.J., Gineyts, E. et al. (1994). Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693–700.

    Article  PubMed  CAS  Google Scholar 

  123. Chesnut, C.H., 3rd, McClung, M.R., Ensrud, K.E. et al. (1995). Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodelling. Am J Med 99:144–52.

    Article  PubMed  CAS  Google Scholar 

  124. Blumsohn, A., Naylor, K.E., Assiri, A.M. et al. (1995). Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget’s disease. Clin Chem 41:1592–8.

    PubMed  CAS  Google Scholar 

  125. Delmas, P.D. (1999). Biochemical markers of bone turnover in Paget’s disease of the bone. J Bone Miner Res 14:66–9.

    PubMed  CAS  Google Scholar 

  126. Garnero, P., Sornay-Rendu, E., Chapuy, M.C. et al. (1996). Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337–49.

    PubMed  CAS  Google Scholar 

  127. Prestwood, K.M., Pilbeam, C.C., Burleson, J.A. et al. (1994). The short term effects of conjugated oestrogen on bone turnover in older women. J Clin Endocrinol Metab 79:366–71.

    Article  PubMed  CAS  Google Scholar 

  128. Hassager, C., Jensen, L.T., Johansen, J.S. et al. (1991). The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones. Metabolism 40:205–8.

    Article  PubMed  CAS  Google Scholar 

  129. Duda, R.J., O’Brien, J.F., Katzmann, J.A. et al. (1988). Concurrent assays of circulating bone GLA protein and bone alkaline phosphatase: effects of sex, age and metabolic bone disease. J Clin Endocrinol Metab 66:951–7.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Chemistry, Nottingham University Hospitals NHS Trust, Nottingham, UK

    Dr Penny Blackwell

  2. Biochemistry Department, Wishaw General Hospital, Wishaw, UK

    Dr Ian M. Godber

  3. Clinical Chemistry, Derby Hospital NHS Foundation Trust, Derby City General Hospital, Derby, UK

    Dr Nigel Lawson

Authors
  1. Dr Penny Blackwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr Ian M. Godber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr Nigel Lawson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Physics & Clinical Engineering Department, Nottingham University Hospitals NHS Trust, Nottingham, UK

    Derek Pearson BSc, PhD (Joint Service Manager) (Joint Service Manager)

  2. Medical Affairs, Bio-Imaging Technologies Inc., Newtown, PA, USA

    Colin G. Miller PhD, FICR (Sr. Vice President) (Sr. Vice President)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag London Limited

About this chapter

Cite this chapter

Blackwell, P., Godber, I.M., Lawson, N. (2007). Biochemical Markers of Bone Turnover. In: Pearson, D., Miller, C.G. (eds) Clinical Trials in Osteoporosis. Clinical Trials. Springer, London. https://doi.org/10.1007/978-1-84628-587-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-587-5_13

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-389-5

  • Online ISBN: 978-1-84628-587-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation